These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20539229)

  • 41. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone.
    Wesson DE; Simoni J; Broglio K; Sheather S
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F830-7. PubMed ID: 21270096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
    Heras M; Fernández-Reyes MJ; Sánchez R; Guerrero MT; Molina A; Rodríguez MA; Alvarez-Ude F
    Nefrologia; 2012 May; 32(3):300-5. PubMed ID: 22508140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances in management of chronic metabolic acidosis in chronic kidney disease.
    Chen W; Abramowitz MK
    Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):409-416. PubMed ID: 31232712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic acidosis: new insights from mouse models.
    Wagner CA
    Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):471-6. PubMed ID: 17693764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease.
    Klaerner G; Shao J; Biyani K; Kade M; Kierstead P; Gbur R; Tabakman S; Nguyen S; Buysse J
    J Pharmacol Exp Ther; 2020 Dec; 375(3):439-450. PubMed ID: 33033169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early diagnosis of CKD and its prevention.
    Amaresan MS; Geetha R
    J Assoc Physicians India; 2008 Jan; 56():41-6. PubMed ID: 18472500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?
    Bodker K; Freidin N; Arora N
    Curr Opin Nephrol Hypertens; 2024 May; 33(3):304-310. PubMed ID: 38420899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein-restricted diets plus keto/amino acids--a valid therapeutic approach for chronic kidney disease patients.
    Aparicio M; Bellizzi V; Chauveau P; Cupisti A; Ecder T; Fouque D; Garneata L; Lin S; Mitch WE; Teplan V; Zakar G; Yu X
    J Ren Nutr; 2012 Mar; 22(2 Suppl):S1-21. PubMed ID: 22365371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of self-management support on the progression of chronic kidney disease--a prospective randomized controlled trial.
    Chen SH; Tsai YF; Sun CY; Wu IW; Lee CC; Wu MS
    Nephrol Dial Transplant; 2011 Nov; 26(11):3560-6. PubMed ID: 21414969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic syndrome and chronic kidney disease.
    Ruan X; Guan Y
    J Diabetes; 2009 Dec; 1(4):236-45. PubMed ID: 20923524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors associated with kidney disease progression and mortality in a referred CKD population.
    Hoefield RA; Kalra PA; Baker P; Lane B; New JP; O'Donoghue DJ; Foley RN; Middleton RJ
    Am J Kidney Dis; 2010 Dec; 56(6):1072-81. PubMed ID: 20692750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic kidney disease and bisphosphonate treatment: are prescribing guidelines unnecessarily restrictive?
    Courtney AE; Maxwell AP
    Postgrad Med J; 2009 Jun; 85(1004):327-30. PubMed ID: 19528309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD.
    Raphael KL
    J Am Soc Nephrol; 2018 Feb; 29(2):376-382. PubMed ID: 29030467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary Treatment of Metabolic Acidosis in Chronic Kidney Disease.
    Siener R
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29677110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No Good Deed: Acidosis in Chronic Kidney and Liver Disease.
    Chandra S; Ravula S; Errabelli P; Spencer H; Singh M
    J Ren Nutr; 2023 May; 33(3):499-502. PubMed ID: 36736470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease.
    Hultin S; Johnson DW; Badve SV
    Curr Opin Nephrol Hypertens; 2021 Sep; 30(5):467-473. PubMed ID: 34009141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease.
    Kraut JA; Madias NE
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):289-297. PubMed ID: 29031355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acidosis and growth in nonuremic renal disease.
    McSherry E
    Kidney Int; 1978 Oct; 14(4):349-54. PubMed ID: 366229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.